Saturn V Capital Management’s Inozyme Pharma INZY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-499,254
Closed -$454K 26
2025
Q1
$454K Sell
499,254
-875,328
-64% -$797K 0.23% 21
2024
Q4
$3.81M Buy
1,374,582
+5,772
+0.4% +$16K 1.49% 17
2024
Q3
$7.16M Buy
1,368,810
+228,500
+20% +$1.2M 2.56% 15
2024
Q2
$5.09M Buy
+1,140,310
New +$5.09M 1.92% 20